218 related articles for article (PubMed ID: 19283923)
1. Perioperative tyrosine kinase inhibitors for GIST: standard ... or an idea that needs further investigation?
von Mehren M; Watson JC
Oncology (Williston Park); 2009 Jan; 23(1):65-6. PubMed ID: 19283923
[No Abstract] [Full Text] [Related]
2. Recent advances in therapy for gastrointestinal stromal tumors.
Maki RG
Curr Oncol Rep; 2007 May; 9(3):165-9. PubMed ID: 17430686
[TBL] [Abstract][Full Text] [Related]
3. Perioperative treatment of gastrointestinal stromal tumors.
Fernandes Gdos S; Blanke CD; Freitas D; Guedes R; Hoff PM
Oncology (Williston Park); 2009 Jan; 23(1):54-61. PubMed ID: 19283922
[TBL] [Abstract][Full Text] [Related]
4. Current management of GISTs.
Blanke C
Clin Adv Hematol Oncol; 2010 May; 8(5):334. PubMed ID: 20551892
[No Abstract] [Full Text] [Related]
5. Sunitinib for imatinib-resistant GIST.
Joensuu H
Lancet; 2006 Oct; 368(9544):1303-4. PubMed ID: 17046443
[No Abstract] [Full Text] [Related]
6. Controversies in the surgical management of GIST in the era of imatinib.
Raut CP; Bertagnolli MM
Oncology (Williston Park); 2009 Jan; 23(1):69, 74-6. PubMed ID: 19283924
[TBL] [Abstract][Full Text] [Related]
7. Evaluation of regorafenib in colorectal cancer and GIST.
Waddell T; Cunningham D
Lancet; 2013 Jan; 381(9863):273-5. PubMed ID: 23177516
[No Abstract] [Full Text] [Related]
8. [Evidence-based treatment of gastrointestinal stromal tumor (GIST) with tyrosine kinase inhibitors-imatinib and sunitinib].
Nishida T; Omori T; Ueshima S
Gan To Kagaku Ryoho; 2011 May; 38(5):733-7. PubMed ID: 21566432
[TBL] [Abstract][Full Text] [Related]
9. Hits and misses in targeting pediatric cancers.
Bernstein ML
Pediatr Blood Cancer; 2009 Jul; 52(7):751-2. PubMed ID: 19185009
[No Abstract] [Full Text] [Related]
10. [Consensus on the medical treatment of gastrointestinal stromal tumors].
Zhonghua Zhong Liu Za Zhi; 2007 Nov; 29(11):875-7. PubMed ID: 18396652
[No Abstract] [Full Text] [Related]
11. Clinical efficacy of second-generation tyrosine kinase inhibitors in imatinib-resistant gastrointestinal stromal tumors: a meta-analysis of recent clinical trials.
Wu L; Zhang Z; Yao H; Liu K; Wen Y; Xiong L
Drug Des Devel Ther; 2014; 8():2061-7. PubMed ID: 25378911
[TBL] [Abstract][Full Text] [Related]
12. Neoadjuvant use of sunitinib in locally advanced GIST with intolerance to imatinib.
Svetlichnaya J; Huyck TK; Wayne JD; Agulnik M
Chemotherapy; 2012; 58(1):30-3. PubMed ID: 22415035
[TBL] [Abstract][Full Text] [Related]
13. Sunitinib treatment in pediatric patients with advanced GIST following failure of imatinib.
Janeway KA; Albritton KH; Van Den Abbeele AD; D'Amato GZ; Pedrazzoli P; Siena S; Picus J; Butrynski JE; Schlemmer M; Heinrich MC; Demetri GD
Pediatr Blood Cancer; 2009 Jul; 52(7):767-71. PubMed ID: 19326424
[TBL] [Abstract][Full Text] [Related]
14. C-kit, GIST, and imatinib.
Siehl J; Thiel E
Recent Results Cancer Res; 2007; 176():145-51. PubMed ID: 17607922
[TBL] [Abstract][Full Text] [Related]
15. Gastrointestinal stromal tumors: current management.
Pisters PW; Patel SR
J Surg Oncol; 2010 Oct; 102(5):530-8. PubMed ID: 20063363
[TBL] [Abstract][Full Text] [Related]
16. [Resistance and treatment strategy of gastrointestinal stromal tumor target therapy].
Lu W; Lu WQ
Zhonghua Wei Chang Wai Ke Za Zhi; 2012 Mar; 15(3):309-12. PubMed ID: 22454182
[TBL] [Abstract][Full Text] [Related]
17. The outcome and predictive factors of sunitinib therapy in advanced gastrointestinal stromal tumors (GIST) after imatinib failure - one institution study.
Rutkowski P; Bylina E; Klimczak A; Switaj T; Falkowski S; Kroc J; Lugowska I; Brzeskwiniewicz M; Melerowicz W; Osuch C; Mierzejewska E; Wasielewski K; Woźniak A; Grzesiakowska U; Nowecki ZI; Siedlecki JA; Limon J
BMC Cancer; 2012 Mar; 12():107. PubMed ID: 22439647
[TBL] [Abstract][Full Text] [Related]
18. [Resistance against tyrosine kinase inhibitors in the treatment of GIST. New therapeutic possibilities appear].
Ahlman H; Nilsson O; Nilsson B
Lakartidningen; 2009 Dec 9-21; 106(50-51):3424-9. PubMed ID: 20180446
[No Abstract] [Full Text] [Related]
19. [Focus on GIST management].
Tardieu M; Dômont J; Cioffi A; Bonvalot S; Le Cesne A
Bull Cancer; 2010 Jun; 97(6):723-31. PubMed ID: 20483709
[TBL] [Abstract][Full Text] [Related]
20. Gastrointestinal stromal tumors: imatinib and beyond.
Schnadig ID; Blanke CD
Curr Treat Options Oncol; 2006 Nov; 7(6):427-37. PubMed ID: 17032555
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]